title: Aldose reductase inhibitor counteracts the attenuated adhesion of human corneal epithelial cells induced by high glucose through modulation of MMP-10 expression.
abstract: OBJECTIVE
  We investigated the preventive effect of aldose reductase inhibitor (ARI) on the adhesion of SV40-transformed human corneal epithelial cells (HCECs) exposed to high glucose, and the underlying mechanism focusing on the role of matrix metalloproteinase (MMP)-10.
  
  
  METHODS
  HCECs were cultured in medium containing a normal (5.5 mM) or high (31.2 mM) concentration of D-glucose in the presence or absence of ARI, fidarestat. Cell attachment ability was evaluated by short-term adhesion assay. The levels of intracellular polyol were measured by liquid-gas chromatography. Real-time reverse transcriptase-polymerase chain reaction (RT-PCR), and Western blotting were used to determine the expression levels.
  
  
  RESULTS
  Decreased attachment activity and increased accumulation of polyol induced by exposure to high glucose were abrogated by ARI. Supply of recombinant MMP-10 decreased integrin alpha3beta1-expression and cell adhesion. The expression level of MMP-10 was enhanced at both protein and mRNA levels by exposure to high glucose, while that of integrin alpha3beta1 was decreased at the protein level, but remained unchanged at the mRNA level. These alterations in the expression levels of MMP-10 and integrin alpha3beta1 were normalized by ARI.
  
  
  CONCLUSIONS
  ARI counteracts the decreased adhesion of HCECs induced by high glucose exposure, through the modulation of the expression of MMP-10.
authors.affiliation: Department of Ophthalmology, Faculty of Medical Sciences, University of Fukui, Eiheiji-cho, Yoshida-gun, Fukui, 910-1193, Japan.
authors.forename: Takeshi
authors.initials: T
authors.lastname: Tomomatsu
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Takamura
authors.forename: Eri
authors.initials: E
authors.lastname: Kubo
authors.forename: Yoshio
authors.initials: Y
authors.lastname: Akagi
mesh_terms: D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D015153:Blotting, Western; D002448:Cell Adhesion / Q000187:drug effects*; D002478:Cells, Cultured; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D004847:Epithelial Cells / Q000166:cytology / Q000187:drug effects*; D019573:Epithelium, Corneal / Q000166:cytology*; D005947:Glucose / Q000494:pharmacology*; D006801:Humans; D039201:Integrin alpha3beta1 / Q000235:genetics / Q000378:metabolism; D053506:Matrix Metalloproteinase 10 / Q000235:genetics / Q000378:metabolism*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013549:Sweetening Agents / Q000494:pharmacology*
chemical_list: D004791:Enzyme Inhibitors; D039201:Integrin alpha3beta1; D013549:Sweetening Agents; D000449:Aldehyde Reductase; D053506:Matrix Metalloproteinase 10; D005947:Glucose